Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propiverine ER vs IR in Neurogenic Detrusor Overactivity
NCT01530620Phase 3Completed
- Sponsor
- APOGEPHA
- Start
- Dec 2004
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of propiverine in neurogenic detrusor overactivity (NDO), sponsored by APOGEPHA. Started Dec 2004; status: completed.
02
Drugs
propiverine
03
Conditions
neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT01530620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01530620.